According to MeiraGTx's latest financial reports the company's current EPS (TTM) is -$2.56. In 2022 the company made an earnings per share (EPS) of -$2.87 a decrease over its 2021 EPS that were of -$1.81.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.56 | -10.8% |
2022 | -$2.87 | 58.56% |
2021 | -$1.81 | 17.53% |
2020 | -$1.54 | -7.78% |
2019 | -$1.67 | -59.15% |
2018 | -$4.09 | 146.92% |
2017 | -$1.66 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$2.06 | -19.53% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$6.20 | 142.19% | ๐ฌ๐ง UK |
Novavax NVAX | -$7.19 | 180.86% | ๐บ๐ธ USA |
Novocure
NVCR | -$1.86 | -27.34% | Jersey |